niacinamide has been researched along with Tumor Lysis Syndrome in 4 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
Tumor Lysis Syndrome: A syndrome resulting from cytotoxic therapy, occurring generally in aggressive, rapidly proliferating lymphoproliferative disorders. It is characterized by combinations of hyperuricemia, lactic acidosis, hyperkalemia, hyperphosphatemia and hypocalcemia.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Tumor lysis syndrome was suspected and intensive hemodialysis was performed." | 5.35 | Sorafenib induced tumor lysis syndrome in an advanced hepatocellular carcinoma patient. ( Huang, WS; Yang, CH, 2009) |
| "Tumor lysis syndrome is rare in hepatocellular carcinoma (HCC), but it has been reported more frequently recently in response to treatments such as transcatheter arterial chemoembolization (TACE), radiofrequency thermal ablation (RFTA), and sorafenib." | 3.81 | Low-dose steroid-induced tumor lysis syndrome in a hepatocellular carcinoma patient. ( Choi, HS; Hahm, JS; Jun, DW; Kim, JO; Lee, HL; Lee, KN; Lee, OY; Tae, HJ; Yoon, BC, 2015) |
| "Tumor lysis syndrome was suspected and intensive hemodialysis was performed." | 1.35 | Sorafenib induced tumor lysis syndrome in an advanced hepatocellular carcinoma patient. ( Huang, WS; Yang, CH, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, JO | 1 |
| Jun, DW | 1 |
| Tae, HJ | 1 |
| Lee, KN | 1 |
| Lee, HL | 1 |
| Lee, OY | 1 |
| Choi, HS | 1 |
| Yoon, BC | 1 |
| Hahm, JS | 1 |
| Huang, WS | 1 |
| Yang, CH | 1 |
| Joshita, S | 1 |
| Yoshizawa, K | 1 |
| Sano, K | 1 |
| Kobayashi, S | 1 |
| Sekiguchi, T | 1 |
| Morita, S | 1 |
| Kamijo, A | 1 |
| Komatsu, M | 1 |
| Umemura, T | 1 |
| Ichijo, T | 1 |
| Matsumoto, A | 1 |
| Tanaka, E | 1 |
| Abbass, K | 1 |
| Dewani, S | 1 |
| Markert, R | 1 |
| Kaplon, MK | 1 |
| Baumann, MA | 1 |
4 other studies available for niacinamide and Tumor Lysis Syndrome
| Article | Year |
|---|---|
Low-dose steroid-induced tumor lysis syndrome in a hepatocellular carcinoma patient.
Topics: Acute Kidney Injury; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembol | 2015 |
Sorafenib induced tumor lysis syndrome in an advanced hepatocellular carcinoma patient.
Topics: Benzenesulfonates; Carcinoma, Hepatocellular; Fatal Outcome; Humans; Liver Neoplasms; Male; Middle A | 2009 |
A patient with advanced hepatocellular carcinoma treated with sorafenib tosylate showed massive tumor lysis with avoidance of tumor lysis syndrome.
Topics: Adult; Benzenesulfonates; Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Male; Niacinamide; Phe | 2010 |
All that glitters: sorafenib.
Topics: Antineoplastic Agents; Benzenesulfonates; Carcinoma, Hepatocellular; Fatal Outcome; Humans; Liver Ne | 2011 |